SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,778,000 | +0.9% | 426,549 | -0.9% | 0.00% | 0.0% |
| Q2 2017 | $4,737,000 | -2.2% | 430,552 | -12.9% | 0.00% | -20.0% |
| Q1 2017 | $4,846,000 | -9.9% | 494,452 | -0.7% | 0.01% | -16.7% |
| Q4 2016 | $5,376,000 | +7.7% | 497,707 | +2.2% | 0.01% | 0.0% |
| Q3 2016 | $4,990,000 | -20.0% | 486,820 | +1.9% | 0.01% | -25.0% |
| Q2 2016 | $6,238,000 | +22.1% | 477,634 | +2.9% | 0.01% | +14.3% |
| Q1 2016 | $5,109,000 | +8.6% | 464,389 | -9.2% | 0.01% | +16.7% |
| Q4 2015 | $4,705,000 | +26.6% | 511,350 | -4.5% | 0.01% | +20.0% |
| Q3 2015 | $3,715,000 | -23.5% | 535,231 | +8.2% | 0.01% | -28.6% |
| Q2 2015 | $4,856,000 | +26.5% | 494,440 | +14.1% | 0.01% | +40.0% |
| Q1 2015 | $3,840,000 | +21.3% | 433,333 | +19.9% | 0.01% | 0.0% |
| Q4 2014 | $3,165,000 | +129.8% | 361,269 | +80.8% | 0.01% | +150.0% |
| Q3 2014 | $1,377,000 | +125.0% | 199,789 | +71.7% | 0.00% | +100.0% |
| Q2 2014 | $612,000 | +14.8% | 116,335 | -0.7% | 0.00% | 0.0% |
| Q1 2014 | $533,000 | -7.5% | 117,135 | +2.6% | 0.00% | 0.0% |
| Q4 2013 | $576,000 | +2.3% | 114,135 | +3.3% | 0.00% | 0.0% |
| Q3 2013 | $563,000 | -5.4% | 110,535 | -1.4% | 0.00% | 0.0% |
| Q2 2013 | $595,000 | – | 112,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|